Sign in

CIK 0001528115 · Non-accelerated filer<br>Smaller reporting company

Annexon, Inc.

Sign in to watch
Ticker
ANNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
275414423
Phone
(650) 822-5500
Business address
1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
  1. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  2. 4 Open-market buy Director bought 8,000 shares at $5.67 ($45,360)
  3. 4 Open-market sale CHIEF MEDICAL OFFICER sold 5,820 shares at $5.43 ($31,603)
  4. 4 Open-market sale EVP & CHIEF BUSINESS OFFICER sold 4,339 shares at $5.42 ($23,517)
  5. 4 Open-market sale EVP & CHIEF INNOVATION OFFICER sold 5,566 shares at $5.42 ($30,168)
  6. 4 Open-market sale EVP & CHIEF SCIENTIFIC OFFICER sold 5,894 shares at $5.43 ($32,004)
  7. 4 Open-market sale EVP & CHIEF FINANCIAL OFFICER sold 5,565 shares at $5.42 ($30,162)
  8. 144 Insider Sale of Securities
  9. 144 Insider Sale of Securities
  10. 144 Insider Sale of Securities
  11. 144 Insider Sale of Securities
  12. 144 Insider Sale of Securities
  13. 4 Derivatives Options or other derivatives
  14. 4 Grant or award CHIEF MEDICAL OFFICER acquired 56,250 shares (grant or award)
  15. 4 Grant or award EVP & CHIEF BUSINESS OFFICER acquired 62,500 shares (grant or award)
  16. 4 Grant or award EVP & CHIEF SCIENTIFIC OFFICER acquired 62,500 shares (grant or award)
  17. 4 Grant or award EVP & CHIEF INNOVATION OFFICER acquired 62,500 shares (grant or award)
  18. 4 Grant or award EVP & CHIEF FINANCIAL OFFICER acquired 62,500 shares (grant or award)
  19. 4 Open-market sale CHIEF MEDICAL OFFICER sold 5,290 shares at $5.10 ($26,979)
  20. 4 Open-market sale EVP & CHIEF FINANCIAL OFFICER sold 7,851 shares at $5.11 ($40,119)

Page 3 of 27 · 524 filings